Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Labcorp Holdings Inc.

Market Cap 20.98B 18.29B 16.94B 15.86B 29.74B 1,979B 29.92B 201B 77.88B 974B 78.74B 77.05B 3,383B P/E 2026 *
17.8x
P/E 2027 * 16.6x
Enterprise Value 25.61B 22.33B 20.68B 19.36B 36.31B 2,417B 36.53B 245B 95.09B 1,189B 96.14B 94.08B 4,130B EV / Sales 2026 *
1.74x
EV / Sales 2027 * 1.62x
Free-Float
99.65%
Yield 2026 *
1.14%
Yield 2027 * 1.15%
1 day-1.44%
1 week-3.88%
Current month-1.63%
1 month+0.03%
3 months-2.73%
6 months+1.50%
Current year+1.97%
1 week 254.03
Extreme 254.03
267.8
1 month 253.06
Extreme 253.055
275
Current year 245
Extreme 245
292.02
1 year 241.81
Extreme 241.81
293.72
3 years 191.97
Extreme 191.97
293.72
5 years 191.97
Extreme 191.97
317.17
10 years 98.02
Extreme 98.02
317.17
Date Insider Type Main position Quantity % Market Cap.
06-07Sell

General Counsel

-762 0.0009%
05-10Sell

Chief Executive Officer

-5,903 0.0072%
03-25Free

Executive/Senior Manager

1,665 0.0020%
Change 5-day change 1-year change 3-year change Capi.($)
-1.44%-3.88%-2.31%+9.80% 20.98B
+2.19%+9.12%+34.65%+339.27% 33.14B
0.00%+0.68%-22.64%-42.82% 6.95B
+1.74%-5.24%-2.70%+66.33% 4.23B
-1.63%+2.14%+12.34%+46.59% 2.9B
+4.59%-1.52%-11.93%+857.95% 1.75B
+0.37%-2.73%-8.76%-66.64% 1.68B
+0.39%-7.83%+34.22%-30.28% 1.65B
-1.84%-1.65%+14.32%-5.03% 1.58B
-2.25%+25.18% - - 1.49B
Average +0.22%-2.20%+5.24%+130.58% 7.63B
Weighted average by Cap. +0.64%+0.64%+13.50%+172.36%

Financials

2026 *2027 *
Net sales 14.76B 12.87B 11.92B 11.16B 20.92B 1,393B 21.05B 141B 54.79B 685B 55.4B 54.21B 2,380B 15.42B 13.44B 12.45B 11.66B 21.86B 1,455B 21.99B 148B 57.25B 716B 57.88B 56.64B 2,487B
Net income 1.18B 1.03B 955M 894M 1.68B 112B 1.69B 11.33B 4.39B 54.91B 4.44B 4.34B 191B 1.23B 1.08B 997M 933M 1.75B 116B 1.76B 11.82B 4.58B 57.32B 4.63B 4.53B 199B
Net Debt 4.63B 4.04B 3.74B 3.5B 6.57B 437B 6.61B 44.39B 17.2B 215B 17.39B 17.02B 747B 3.94B 3.44B 3.18B 2.98B 5.59B 372B 5.62B 37.77B 14.64B 183B 14.8B 14.48B 636B
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Employees
66,385
Date Price Change Volume
26-06-18 255.82 $ -1.44% 1,249,804
26-06-17 259.56 $ -1.96% 544,046
26-06-16 264.76 $ -0.10% 510,658
26-06-15 265.03 $ -0.42% 461,451
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
255.82USD
Average target price
310.12USD
Spread / Average Target
+21.22%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!